• Home
  • Emily’s Story
  • About Us
    • About Emily’s Entourage
    • Our Approach
    • Our Impact
      • 2022-2023 Impact Report
      • 2021 Impact Report
      • 2020 Impact Report
      • 2019 Impact Report
    • About Cystic Fibrosis
    • Meet Our Leadership
      • Scientific Advisory Board
      • Board of Directors
      • Leadership Team
    • Partner Organizations
  • Research
    • Areas of Focus
    • Awarded Grants
    • Funding Opportunities
      • Venture Philanthropy Investments
      • Collaborative Grants
      • Translational Grants
    • CF Clinical Trial Connect
    • Clinical Trial Matchmaking Program
    • The Final 10% Survey
    • Publications
    • For Researchers
      • Research Inquiries
      • Research Resources
  • Events
    • 2025 EE Gala
    • Events & Activities
  • Press & Media
    • EE in the News
    • Press Releases
    • Awards
    • Videos
  • Take action
    • Donate
    • Get Involved
    • Join CF Clinical Trial Connect
    • Shop EE
    • Sign Up for Updates
  • Blog
  • Contact
  • Donate
DONATE
  • Home
  • Emily’s Story
  • About Us
    • About Emily’s Entourage
    • Our Approach
    • Our Impact
      • 2022-2023 Impact Report
      • 2021 Impact Report
      • 2020 Impact Report
      • 2019 Impact Report
    • About Cystic Fibrosis
    • Meet Our Leadership
      • Scientific Advisory Board
      • Board of Directors
      • Leadership Team
    • Partner Organizations
  • Research
    • Areas of Focus
    • Awarded Grants
    • Funding Opportunities
      • Venture Philanthropy Investments
      • Collaborative Grants
      • Translational Grants
    • CF Clinical Trial Connect
    • Clinical Trial Matchmaking Program
    • The Final 10% Survey
    • Publications
    • For Researchers
      • Research Inquiries
      • Research Resources
  • Events
    • 2025 EE Gala
    • Events & Activities
  • Press & Media
    • EE in the News
    • Press Releases
    • Awards
    • Videos
  • Take action
    • Donate
    • Get Involved
    • Join CF Clinical Trial Connect
    • Shop EE
    • Sign Up for Updates
  • Blog
  • Contact
  • Donate

30 Apr 2025

Keep Moving Forward: Tips For Staying Positive in The Final 10%

During CF Awareness Month, Emily’s Entourage invites members of the cystic fibrosis (CF) community to share their stories. Today’s blog post highlights the story of Jarrod Landau, an adult with CF.

Living with cystic fibrosis (CF) has always been a challenge, but for the majority of people with CF, the arrival of mutation targeted therapies (CFTR modulators) has transformed daily life, dramatically reducing the treatment burden and improving health outcomes. However, for the final 10% of the CF population—including myself—these breakthroughs don’t work. Our mutations don’t respond to modulators, leaving us in a holding pattern as we wait for the next wave of scientific advancements.

Being in this minority shapes every aspect of my daily routine. It’s a unique space to occupy—watching others experience dramatic health improvements while knowing that, for now, my options remain the same while my disease continues to advance. But rather than dwell on what I don’t have, I focus on what I can control. Through years of trial and error, I’ve developed strategies to stay positive, hopeful, and proactive while navigating life in the final 10%.

Focusing on What’s in My Control

One of the most powerful tools I’ve developed is a mindset shift: instead of fixating on what’s missing, I focus on what I can influence. My health, my outlook, and my actions are all within my control, and I make them my priorities.

A cornerstone of this approach is my treatment regimen. I take every medication and complete every therapy session without fail. It’s a significant time commitment—about three hours per day—but it’s non-negotiable. Over time, I’ve built my routine in a way that integrates treatment into my life rather than allowing it to take over. Since I do most of my treatments at my desk, I can watch IPTV, read, or work on my computer at the same time. When I was a kid, this kind of multitasking wasn’t possible. Now, these small adaptations make a world of difference in making my treatment burden feel more manageable.

The key is to keep moving forward, even when progress feels slow. While my daily routine may not come with the immediate benefits that mutation-targeted therapies provide for others, I find comfort in knowing that I’m doing everything in my power to stay as healthy as possible.

Small Wins and Incremental Progress

In a world where medical breakthroughs often feel like all-or-nothing events, I’ve learned to celebrate small wins. These may seem insignificant from the outside, but they’re vital for maintaining motivation and resilience.

Some days, a small win looks like finishing a workout I didn’t feel up to starting. Other days, it’s discovering a new supplement, treatment approach, or research study that gives me a renewed sense of possibility. When facing an exacerbation, or worsening of my CF pulmonary symptoms,, I look for ways to adjust my routine to optimize my recovery. Every little step adds up, and collectively, they fuel my perseverance.

For me, progress isn’t just about waiting for the next big breakthrough—it’s about actively seeking ways to improve my daily quality of life. Every time I refine my treatment approach or find a new strategy that helps me feel better, I’m moving in the right direction.

Exercise as a Tool for Mental and Physical Strength

Another fundamental part of my strategy is exercise. While it’s well-documented that physical activity is beneficial for people with CF, I view it as more than just a way to keep my lungs clear—it’s a mental reset, a form of self-empowerment.

There’s something about pushing through a difficult workout that reinforces my inner resilience. When I do intervals, swim, or walk up a steep hill, my mind often tells me I can’t go any further—but I push through anyway. I use exercise as a way to remind myself that I’m in control, that I can challenge my body and come out stronger.

This mindset has been invaluable, especially during times when my health has been unpredictable. Exercise teaches me that struggle doesn’t mean defeat—it’s just a step in the process.

The Power of Community and Support

While self-discipline is crucial, I’ve also learned that I can’t navigate this journey alone. The CF community, particularly those of us in the final 10%, plays a huge role in keeping me motivated and hopeful.

One of the most meaningful ways I stay connected is through organizations like Emily’s Entourage. This group focuses on accelerating research for people with CF who don’t benefit from existing mutation-targeted therapies, and being involved gives me a sense of purpose. Knowing that people are relentlessly pursuing  solutions specifically for our community makes a world of difference.

Holding Onto Hope for the Future

Though it can be frustrating to wait for new treatments, I refuse to lose hope. Advances in gene therapy and mRNA-based treatments are progressing rapidly, and it’s only a matter of time before solutions emerge for the final 10%. The science is evolving, and I believe the breakthroughs we need are within reach.

In the meantime, I channel my hope into action. I stay engaged in research, I take care of my health, and I embrace the mindset that every step forward—no matter how small—is worth celebrating.

For those of us in the final 10%, the road ahead may feel uncertain, but history has shown that progress never stops. Hope is our most powerful tool, and as long as we keep pushing forward, the breakthroughs we need will come.

Author

Jarrod Landau is an adult living with cystic fibrosis in Australia.

CF stories, cfa, cfa month, cystic fibrosis awareness, cystic fibrosis awareness month
Share Post: facebook-share linked-share twitter-share
Lines of Progress: My Journey from Critical Illness to Change-Making Advocacy
CF Before Birth: How One Couple Used Modulators for In Utero Treatment to Improve Health Outcomes for Their Child
The opinions stated by our guest contributors reflect the experiences and thoughts of the author alone. Our publication of these pieces does not reflect Emily’s Entourage’s endorsement or suggest a position on those opinions. The content on this site is for informational or educational purposes only and does not substitute professional medical advice or consultations with healthcare professionals.
  • Emily's Entourage Nonprofit Overview and Reviews on GreatNonprofits
    Volunteer. Donate. Review.
  • Home
  • About Emily’s Entourage
  • Careers
  • Contact Us
  • Donate
Sign Up for Updates >>

Emily’s Entourage
PO Box 71
Merion Station, PA 19066

Tax ID #45-3768161

Emily's Entourage
Website Managed By: Strategic Websites
  • Home
  • Emily’s Story
  • About Us
    ▼
    • About Emily’s Entourage
    • Our Approach
    • Our Impact
      ▼
      • 2022-2023 Impact Report
      • 2021 Impact Report
      • 2020 Impact Report
      • 2019 Impact Report
    • About Cystic Fibrosis
    • Meet Our Leadership
      ▼
      • Scientific Advisory Board
      • Board of Directors
      • Leadership Team
    • Partner Organizations
  • Research
    ▼
    • Areas of Focus
    • Awarded Grants
    • Funding Opportunities
      ▼
      • Venture Philanthropy Investments
      • Collaborative Grants
      • Translational Grants
    • CF Clinical Trial Connect
    • Clinical Trial Matchmaking Program
    • The Final 10% Survey
    • Publications
    • For Researchers
      ▼
      • Research Inquiries
      • Research Resources
  • Events
    ▼
    • 2025 EE Gala
    • Events & Activities
  • Press & Media
    ▼
    • EE in the News
    • Press Releases
    • Awards
    • Videos
  • Take action
    ▼
    • Donate
    • Get Involved
    • Join CF Clinical Trial Connect
    • Shop EE
    • Sign Up for Updates
  • Blog
  • Contact
  • Donate
English
Español Português Português do Brasil עִבְרִית Français Français du Canada Italiano Türkçe Svenska Deutsch